Novel-Type GABA_B PAMs: Structure-Activity Relationship in Light of the Protein Structure

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• GABA B receptors are critical targets for neurological disorders.
• Positive allosteric modulators (PAMs) offer a therapeutic strategy for modulating GABA B receptor activity.
• Existing GABA B PAMs require optimization for improved potency and drug-like properties.

Purpose of the Study:

• To optimize a pyrazolo[1,5-a]pyrimidine hit compound for enhanced GABA B receptor positive allosteric modulator (PAM) activity.
• To identify novel interactions that improve potency without compromising physicochemical properties.
• To elucidate the binding mode of optimized compounds using structural information.

Main Methods:

• Ligand-based pharmacophore modeling was employed for optimization.
• Lipophilic ligand efficiency (LLE) was incorporated as an objective function.
• Analysis of publicly available GABA B receptor structures was performed to rationalize binding.

Main Results:

• Optimization led to a novel carboxylic acid derivative (compound 34).
• Compound 34 demonstrated improved potency while maintaining favorable physicochemical properties.
• The carboxylic acid moiety was identified as a key pharmacophore element for GABA B PAM activity.

Conclusions:

• The study successfully identified a lead compound with enhanced GABA B PAM properties.
• The novel carboxylic acid feature is critical for potent allosteric modulation of GABA B receptors.
• Structural analysis provides a rational basis for the observed activity and guides future drug design.